Patent Assignment
Reel/Frame 064178/0212
Assignment of Assignor's Interest
Recorded: 2023-07-07
Pages: 15
Assignor
MAGENTA THERAPEUTICS, INC.
Executed: 2023-04-14
Assignee
HEIDELBERG PHARMA RESEARCH GMBH
GREGOR-MENDEL-STRASSE 22, LADENBURG, 68526, GERMANY
Covered Properties
(7)
Compositions and Methods for the Depletion of CD137+ Cells
Use of Anti-CD137 Antibody Drug Conjugate (Adc) in Allogeneic Cell Therapy
Compositions and Methods for the Depletion of CD5+ Cells
Use of Anti-CD5 Antibody Drug Conjugate (Adc) in Allogeneic Cell Therapy
T-Cell Depleting Therapies
Application:
17/457,607 →
Publication:
US 2022/0249683
Compositions and Methods for the Depletion of CD137+ Cells
Compositions and Methods for the Depletion of CD137+ Cells
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 25, 2019
From: HARTIGAN, ADAM; BOITANO, ANTHONY; COOKE, MICHAEL; HOBAN, MEGAN D.
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 048994/0565 →
Assignment of Assignor's Interest
May 2, 2019
From: HARTIGAN, ADAM; BOITANO, ANTHONY; COOKE, MICHAEL; HOBAN, MEGAN D.
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 049063/0820 →
Assignment of Assignor's Interest
Nov 7, 2024
From: BOITANO, ANTHONY; COOKE, MICHAEL; PALCHAUDHURI, RAHUL; MCDONOUGH, SEAN
To: MAGENTA THERAPEUTICS, INC.
Reel/Frame 069182/0708 →
Assignment of Assignor's Interest
Nov 7, 2024
From: MAGENTA THERAPEUTICS, INC.
To: HEIDELBERG PHARMA RESEARCH GMBH
Reel/Frame 069183/0032 →
Corrective Assignment to Correct the Correct the Assignee's Postal Code from "68256" to "68526" Previously Recorded at Reel: 69183 Frame: 32. Assignor(S) Hereby Confirms the Assignment.
Nov 13, 2024
From: MAGENTA THERAPEUTICS, INC.
To: HEIDELBERG PHARMA RESEARCH GMBH
Reel/Frame 069351/0945 →